Company Wuhan General Group (China), Inc.
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
Business Summary
Number of employees: 700
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids and Psilocybin Medical Research
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 88-07-18 |
Willem Jonker
DFI | Director of Finance/CFO | - | 20-10-04 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Chief Tech/Sci/R&D Officer | - | 19-01-21 | |
Warren Kansley
SAM | Sales & Marketing | - | - |
Robert Simbowe
PRN | Corporate Officer/Principal | - | 21-05-23 |
Rameez Adair
PRN | Corporate Officer/Principal | - | 20-06-02 |
Corporate Officer/Principal | - | 20-06-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-01-21 | |
Jeff Robinson
FOU | Founder | - | 88-07-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,354,078 | 0 | 0 | 76.65 % |
Stock B | 1 | 55,149,662 | 42,271,310 ( 76.65 %) | 0 | |
Stock C | 0 | 6,241,453 | 0 | 0 |
Company contact information
Wuhan General Group (China), Inc.
Unit 01, Mason's Press 7 Ravenscraig Road
7925, Cape Town
+
http://www.m2bio.coSector
1st Jan change | Capi. | |
---|---|---|
-99.00% | 55 | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- WUHN Stock
- Company Wuhan General Group (China), Inc.